our brain tumor cocktails and stories
Pages
(Move to ...)
Home
User Information
Brain Tumor Library
Drug Interactions
Drug Dosing
Toxicities
Drug and Supplement sources
Handy links
▼
Wednesday, 29 November 2017
Orphan Drug Status for BXQ-350
FDA granted Bexion Orphan Drug status for Saposin C, the active ingredient in its proprietary drug BXQ-350, for the potential treatment of glioblastoma.
http://bit.ly/2AlVuGb
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment